Off Label · Issue 02 · August 11, 2026
The 2002 headline that's still costing people their vitality
One drug combination. One population. Twenty years of fear. Here's what the evidence actually says.
Off Label is education, not medical advice. Talk to your own clinician before you change anything.
Two of the most common things I hear are versions of the same sentence.
A woman told to tough out menopause because hormones cause cancer. A man told his testosterone is normal for his age while he feels like a shell of himself.
Both are living inside the shadow of a headline from 2002. If you or someone you love is in that spot, this might be the most useful thing you read this month.
The science in one breath
In 2002, a large trial called the Women's Health Initiative was stopped early. The finding that hit the news: hormone therapy raised breast cancer risk by 26 percent. Overnight, millions of women quit, a generation of doctors stopped prescribing, and the next generation of doctors stopped learning how to prescribe it.
And here's the detail almost nobody mentions: that study tested one specific formulation. Conjugated estrogens made from horse urine, paired with a synthetic progestin, taken as a pill. Not the estradiol most women are prescribed today, not a patch, not body-identical progesterone. We took the results of one drug combination in one population and applied them to an entire category of medicine for twenty years.
Subscribe free to keep reading
Join 16,000+ readers getting Off Label: evidence-based health you can actually use, one to two emails a month. Subscribing unlocks this issue, every past one, and my free Weekly Protocol.
Here is the other part that never made the headline. That 26 percent was a relative number. In absolute terms it worked out to about 8 extra breast cancer cases per 10,000 women per year. Real, but small. And the average woman in that study was 63, more than a decade past menopause, which is not who was asking for help.
When you look at women who start near menopause, the story flips. This is called the timing hypothesis. The ELITE trial showed slowed plaque progression when estrogen was started early, and the WHI's own subgroup data showed lower all-cause mortality in the women who began before 60. The estrogen-only group, women who had a hysterectomy, actually had less breast cancer and fewer breast cancer deaths twenty years later, not more.
Today the major menopause society is clear: hormone therapy is the single most effective treatment for hot flashes and the genital and urinary changes of menopause, and it protects bone. Modern delivery matters too. The data we have suggests an estrogen patch instead of a pill, paired with body-identical progesterone, lowers the old clot and breast cancer concerns further.
Men got their own version of the fear. For years testosterone carried a warning that it might cause heart attacks. It also was demonized in the sports world, where athletes were busted for taking insane doses, and that fear carried over into clinical practice after testosterone was labeled as a controlled substance. So in 2023 a trial of more than 5,000 men put it to the test. Testosterone did not raise the rate of heart attacks or strokes compared to placebo. And the old worry that testosterone feeds prostate cancer has not borne out in the trials we have.
Here is where I want to be honest, because the internet is not. Testosterone reliably helps libido, sexual function, and quality of life. Its effects on energy, mood, and focus are real for some men but smaller than the hype sells. It is a tool, not a personality.
The protocol
Hormones are prescription medicines, individualized, and not for everyone. This is not a screenshot-a-dose situation. It is a find-the-right-guide situation. Here is how to approach it well.
- Start with symptoms, not just a lab. How you sleep, feel, think, and function is the real target.
- Find a clinician who treats symptoms and monitors carefully. For women, a menopause-certified provider. For men, someone who checks your blood count and prostate markers over time, not a clinic that hands out vials.
- Ask about route and formulation. For women, a transdermal estrogen with micronized progesterone is a common modern starting point. For men, the plan should include a monitoring schedule from day one.
- Judge it by how you feel and function, then retest and adjust. Optimization is a loop, not a one-time prescription.
- Respect the contraindications. Certain cancers, a history of clots, and other conditions can take hormones off the table. A good clinician screens for these first.
Notice the through-line. When someone finally sleeps through the night, has energy for the gym, gets their drive back, and feels like themselves, everything downstream gets easier. Feeling better is not the vanity goal at the end. It is often the lever that moves everything else.
If you do one thing
If you or your partner has been told to just live with it, get one more opinion from a clinician who treats how you feel, not only where you fall in a lab range. The answer might still be no. But you deserve to have the real conversation.
None of this means hormones are for everyone, and anyone selling them that way is selling, not treating. It means the fear that shut the door in 2002 was bigger than the facts, and a lot of people have been suffering behind that door for no good reason.
Stay healthy, Clay Moss, MD